| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |